Abstract:Objective: To evaluate the efficacy and safety of injectable gatifloxacin. Methods; In this multicenter, single-blind, randomized comparative study, patients with infection of lower respiratory tract and urinary tract were allocated randomly to gatifloxacin group or levofloxacin group. In each group patients were given gatifloxacin or levofloxacin intrevenously for 3-5 d followed by oral formulation. Results: (1)The clinical effective rates (gatifloxacin vs. levofloxacin) were 92.4%(110/119) vs. 91.2%(114/ 125), being 94.296(65/69) vs. 90.296(65/72) for lower respiratory tract infections and 90.0% (45/50) vs. 92.5%(42/72) for urinary tract infections, respectively, there was no statistically significant difference between the two groups; (2)The total bacterial eradication rates were 94.0% (78/83) vs. 88.0% (81/92), being 89.2% (33/37) vs. 92.9% (39/42) for urinary tract infections, there was no statistically significant difference between the two groups; however, the bacterial eradication rate of gatifloxacin (97.8% , 45/46) was higher than that of levofloxacin (84. 3% , 43/51) in lower respiratory tract infections, the difference was statistically significant. (3)Drug-related adverse effects were 29.9% (38/127) in gatifloxacin group, higher than that in levofloxacin group 10.1% (13/129). This is due to more patients with phlebitis and gastrointestinal symptoms in gatifloxacin group than those in levofloxacin group. These drug-related events could be alleviated by slowing down the speed of infusion; the adverse effects of both groups were mild and tolerable, no discontinuation of treatment due to adverse reaction. Drug-related abnormal laboratory findings oc- carred in gatifloxacin group and levefloxacin group were 24. 8% (30 /121) and 22. 1 % (27 /112) respectively. All were mild and transient, and there was no statistically significant difference between the two groups. Conclusions: Gatifloxacin given intravenously used as initial therapy in infectious patients with systemic clinical manifestations and followed by oral administration for the completion of therapy may get satisfactory results. The clinical efficacy of gatifloxacin is as good as that of levofloxacin. The adverse reaction rate of gatifloxacin was slightly higher than that of levofloxacin, but all the reactions are mild and tolerable.

Fleroxacin Vs Ciprofloxacin in Treatment of Bacterial Infection

A Randomized Controlled Clinical Study on Levofloxacin Versus Ciprofloxacin in the Treatment of Bacterial Infections

Clinical randomized controlled trials of Gatifloxacin injection in the treatment of bacterial infections of lower respiratory tract and urinary tract

A clinical randomized controlled trial of pazufloxacin injection in treatment of bacterial infection in 111 patients

Double-blind Randomized Controlled Clinical Trial on Gatifloxacin Versus Levofloxacin Injection for Treating Acute Bacterial Infections

A multiple centre randomized controlled clinical study of sparfloxacin in the acute respiratory tract infections

A randomized comparative study of gatifloxacin and ciprofloxacin in the treatment of bacterial infections

Clinical Randomized Controlled Trials of Gatifloxacin Injection in Treatment of Bacterial Infections of Respiratory Tract

Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis

A Multicenter, Single-Blind, Randomized Comparison of Sequential Therapy of Gatifloxacin Versus Levofloxacin in the Treatment of Bacterial Infections

Clinical evaluation of pazufloxacin and levofloxacin in the treatment of bacterial infections

A Phase Ii Study of Antofloxacin Hydrochloride, A Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections

Clinical study of lomefloxacin compared with ofloxacin in the treatment of bacterial infections

A randomized multicenter clinical study of injectable levofloxacin in the treatment of acute bacterial infections

Randomized Controlled Study on Gatifloxacin and Levofloxacin Injection in the Treatment of Acute Gonococcal Urinary and Reproductive Tract Infections

Randomized Controlled Clinical Trial of Moxifloxacin Versus Levofloxacin Injection in the Treatment of Community Acquired Pneumonia

A Double-Blind, Randomized Controlled Clinical Study:Gatifloxacin Vs Levofloxacin in Treatment of 98 Patients with Urinary Tract Infections

Multi-center Clinical Studies on Pazufloxacin Sodium Chloride Injection in Treatment for Acute Bacterial Infections

A Multi-Center, Randomized, Controlled, Double Blind and Double Dummy Clinical Trial of Antofloxacin Hydrochloride Tablet Versus Levofloxacin Tablet for the Treatment of Acute Bacterial Infections

Molecular characterization and genetic variability at κ-casein gene (CSN3) in camels.

A Randomized Controlled Clinical Study on a New Quinolone,gatifloxacin, in the Treatment of Respiratory Tract Infections